Evidence map›Paper›PMID 34622005›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Radical

Zhassulan Baimakhanov, Shokan Kaniyev, Erbol Serikuly, Maxat Doskhanov, Baglan Askeyev, Dinara Baiguissova, Aidar Skakbayev, Chingiz Sadykov, Raikhan Barlybay, Manas Seisembayev and 1 more

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Zhassulan BaimakhanovDepartment of HPB Surgery and Liver Transplantation Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.ORCID https://orcid.org/0000-0003-1887-7866
Shokan KaniyevDepartment of HPB Surgery and Liver Transplantation Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Erbol SerikulyDepartment of HPB Surgery and Liver Transplantation Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Maxat DoskhanovDepartment of HPB Surgery and Liver Transplantation Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Baglan AskeyevDepartment of HPB Surgery and Liver Transplantation Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Dinara BaiguissovaDepartment of Radiology Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Aidar SkakbayevDepartment of HPB Surgery and Liver Transplantation Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Chingiz SadykovDepartment of Radiology Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Raikhan BarlybayDepartment of Radiology Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Manas SeisembayevDepartment of HPB Surgery and Liver Transplantation Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
Bolatbek BaimakhanovDepartment of HPB Surgery and Liver Transplantation Syzganov's National Scientific Center of Surgery Almaty Kazakhstan.
National Scientific Center for Surgery named after A.N. Syzganov · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimWe prospectively compared the clinical outcomes of radical and conservative surgical procedures for primary liver hydatid cysts, additionally radical surgical procedures with and without the two-month administration of albendazole after the operation were compared.

methodsOverall, 90 patients undergoing open surgical treatment for liver hydatid cysts were divided into three surgical groups: first group, patients who underwent radical surgery (pericystectomy) followed by albendazole treatment for 2 months following the operation group; second group, patients who underwent radical surgery(pericystectomy) without receiving albendazole after surgery group; third group, patients, who underwent conservative surgery (partial cystectomy) with albendazole treatment after surgery. The clinical outcomes and rate of recurrence were analyzed in follow-up period.

resultsThe mean surgery duration in the Radical groups was significantly longer in comparison to the Conservative surgery + Albendazole group. (212.0 and 202.5 min vs. 173.2 min;

conclusionIn comparison to conservative surgery, radical surgery is a preferable treatment modality for patients with active liver hydatid cysts. Postoperative albendazole treatment is preferable, regardless of the type of surgical procedure.

Indexed as

albendazolehepatic echinococcosishydatid cystpostoperative complicationsrecurrence

Identifiers

PMID34622005
PMCPMC8485413
OpenAlexW3197049995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.